4300 Live Notices for Germany Pharmaceutical Products Tenders
Showing 1 to 20
Open House Drug Discount Agreements Botulinum Toxin Type A, Finished Medicinal Product Name Xeomin(R), Atc M03Ax21
17 Jan 2025
05 Jan 2027Consolidated Analytical Platform (Kap) Including Laboratory Automation
Open House Drug Discount Contracts Colecalciferol, Non Rx, Exclusively According To Annex 1 Am-Rl G-Ba Prescribable Products, Atc A11Cc05
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb) V For The Active Ingredient Telmisartan + Amlodipine, (Obg) Atc C09Db04 For The Period 01.03.2025 - 28.02.2027
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V For The Active Ingredient Progesterone Exclusively In The Dosage Form Vka, (Obo) Atc G03Da04 For The Period 01.03.2025 - 28.02.2027
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb) V For The Active Ingredient Elbasvir + Grazoprevir, (Obo) Atc J05Ap54 For The Period 01.03.2025 - 28.02.2027
Rhine-Ruhr 2025 Fisu Games - Framework Agreement On Fences And Soil Protection
Framework Agreement On Professional Skin Products (Vgst1-1-2024-0102)
2025-03-Drug Development-Spectrometer-E23
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V For The Active Ingredient Erythropoietin, Excluding Epoetin Alfa, (Obo) Atc B03Xa01 For The Period 01.03.2025 - 28.02.2027
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb) V For The Active Ingredient Nitisinone, (Obo) Atc A16Ax04 For The Period 01.03.2025 - 28.02.2027
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb) V For The Active Ingredient Ustekinumab, (Obg) Atc L04Ac05 For The Period 01.03.2025 - 28.02.2027
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Atovaquone, (Obg) Atc P01Ax06 For The Period 01.03.2025 - 28.02.2027
Pharmaceutical Discount Agreements Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb V) Within The Framework Of Open-House Procedures
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb) V For The Active Ingredient Bempedoic Acid + Ezetimibe, (Obo) Atc C10Ba10 For The Period 01.03.2025 - 28.02.2027
Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For The Active Ingredient Pegfilgrastim, (Obo) Atc L03Aa13 For The Period 01.03.2025 - 28.02.2026 (Plus Extension Option 1X12 Months)
Social Counseling Services In The Segeberg District - Addiction Counseling
Intention To Conclude A Contract For The Supply Of Medical Aids (Here: Pg03 - Infusion And Drug Therapy (Excluding Parenteral Nutrition)) Including The Associated Services According To Section 127 Paragraph 1 Sgb V
2025-03-Drug Development-Spectrometer-E23
Zaw - Specialist In Warehouse Logistics - Munich | Ml 688
Tenders by Country